Literature DB >> 18086150

Effects of drug hydrophobicity on liposomal stability.

David R Khan1, Evonne M Rezler, Janelle Lauer-Fields, Gregg B Fields.   

Abstract

A major obstacle in drug delivery is the inability to effectively deliver drugs to their intended biological target without deleterious side-effects. Delivery vehicles such as liposomes can minimize toxic side-effects by shielding the drug from reaction with unintended targets while in systemic circulation. Liposomes have the ability to accommodate both hydrophilic and hydrophobic drugs, either in the internal aqueous core or the lipid bilayer, respectively. In the present study, fluorescein and rhodamine have been used to model hydrophilic and hydrophobic drugs, respectively. We have compared the stabilities of liposomes encapsulating these fluorophores as a function of lipid content, time, and temperature. At 25 and 37 degrees C, liposomes containing distearoyl phosphatidylcholine as the major phospholipid component were found to be more stable over time than those containing dipalmitoyl phosphatidylcholine, regardless of the fluorophore encapsulated. Liposomes loaded with fluorescein were found to be more stable than those with rhodamine. Dipalmitoyl phosphatidylcholine liposomes that encapsulated rhodamine were the least stable. The results indicate that the physical properties of the drug cargo play a role in the stability, and hence drug delivery kinetics, of liposomal delivery systems, and desired drug release times can be achieved by adjusting/fine-tuning the lipid compositions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18086150     DOI: 10.1111/j.1747-0285.2007.00610.x

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  22 in total

1.  Highly aspherical silica nanoshells by templating tubular liposomes.

Authors:  Grace Tan; Peng Xu; Jibao He; Louise Lawson; Gary L McPherson; Vijay T John
Journal:  Soft Matter       Date:  2009-07-01       Impact factor: 3.679

Review 2.  The benefits and challenges associated with the use of drug delivery systems in cancer therapy.

Authors:  Edna Cukierman; David R Khan
Journal:  Biochem Pharmacol       Date:  2010-04-22       Impact factor: 5.858

3.  A platelet-mimetic paradigm for metastasis-targeted nanomedicine platforms.

Authors:  Christa L Modery-Pawlowski; Alyssa M Master; Victor Pan; Gregory P Howard; Anirban Sen Gupta
Journal:  Biomacromolecules       Date:  2013-02-14       Impact factor: 6.988

4.  Aerosolized nanoliposomal carrier of remdesivir: an effective alternative for COVID-19 treatment in vitro.

Authors:  Richa Vartak; Suyash M Patil; Aishwarya Saraswat; Manali Patki; Nitesh K Kunda; Ketan Patel
Journal:  Nanomedicine (Lond)       Date:  2021-05-13       Impact factor: 5.307

5.  Characterization of 9-nitrocamptothecin liposomes: anticancer properties and mechanisms on hepatocellular carcinoma in vitro and in vivo.

Authors:  Shunzhen Zheng; Shuang Chang; Jinli Lu; Zhihui Chen; Li Xie; Yu Nie; Bin He; Shengquan Zou; Zhongwei Gu
Journal:  PLoS One       Date:  2011-06-09       Impact factor: 3.240

6.  Nanomedicine for glaucoma: liposomes provide sustained release of latanoprost in the eye.

Authors:  Jayaganesh V Natarajan; Marcus Ang; Anastasia Darwitan; Sujay Chattopadhyay; Tina T Wong; Subbu S Venkatraman
Journal:  Int J Nanomedicine       Date:  2012-01-05

7.  The treatment of breast cancer using liposome technology.

Authors:  Sarah Brown; David R Khan
Journal:  J Drug Deliv       Date:  2012-02-21

8.  Liposomal Doxorubicin in the treatment of breast cancer patients: a review.

Authors:  Juan Lao; Julia Madani; Teresa Puértolas; María Alvarez; Alba Hernández; Roberto Pazo-Cid; Angel Artal; Antonio Antón Torres
Journal:  J Drug Deliv       Date:  2013-03-26

9.  Application of Collagen-Model Triple-Helical Peptide-Amphiphiles for CD44-Targeted Drug Delivery Systems.

Authors:  Margaret W Ndinguri; Alexander Zheleznyak; Janelle L Lauer; Carolyn J Anderson; Gregg B Fields
Journal:  J Drug Deliv       Date:  2012-11-14

Review 10.  Use of Targeted Liposome-based Chemotherapeutics to Treat Breast Cancer.

Authors:  David R Khan; Maggie N Webb; Thomas H Cadotte; Madison N Gavette
Journal:  Breast Cancer (Auckl)       Date:  2015-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.